SM
RVLP

Scoggin Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Scoggin Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-160,007
Closed -$89.6K – 83
2023
Q2 		$89.6K Sell
160,007
-339,993
-68% -$300K 0.06% 46
2023
Q1 		$570K Buy
+500,000
New +$600K 0.34% 38

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
TAM
Titleist Asset Management San Antonio, Texas $1.49B AUM 22.27% 1-Year Est. Return

Scoggin Management's RVLP Position: Q3 2023 in Review

Scoggin Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2023, closing a stake of 160,007 shares — an estimated $89.6K sold.

Scoggin Management first reported a position in RVLP in Q1 2023 and held it in 2 quarters. The position peaked at $570K in Q1 2023. 32 funds tracked by Wall St. Rank hold RVLP as of Q3 2023.

  • Scoggin Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Scoggin Management sold 160,007 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2023, an estimated $89.6K.
  • Scoggin Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2023 and held it in 2 quarters.
  • Scoggin Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $570K in Q1 2023.
  • 32 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2023.

Based on Scoggin Management's 13F filing for Q3 2023, filed 14 Nov 2023.